therapeutics
4 articles about therapeutics in AI news
DeepMind's AlphaGenome AI Decodes Non-Coding DNA for CRISPR Targeting
Demis Hassabis states that while CRISPR can edit DNA, finding the right target is hard. DeepMind's AlphaGenome AI is analyzing the non-coding genome to predict mutation effects and guide precise CRISPR interventions.
AI Firms Target Biotech for High-Impact, High-Margin Applications
A trend analysis notes AI companies are shifting focus to biotech, where accurate prediction models can be monetized through drug discovery and synthetic biology, creating a new competitive frontier.
Eli Lilly Signs $2.75B AI Drug Discovery Deal with Insilico Medicine
Eli Lilly has entered a $2.75 billion licensing pact with Insilico Medicine for multiple AI-discovered drug programs. The deal includes an upfront payment, milestones, and royalties, marking a major validation for AI-driven pharmaceutical R&D.
From Bota to Enhe: The Dawn of Physical AI in Biomanufacturing
Bota Bio has rebranded as Enhe Technology and launched SAION AI, a pioneering Physical AI platform for biomanufacturing. The platform claims state-of-the-art performance across four key life science AI benchmarks, signaling a major shift in how biology is engineered.